Harman Patil (Editor)

Pateclizumab

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type
  
Whole antibody

Target
  
lymphotoxin alpha

CAS Number
  
1202526-59-7

Source
  
Humanized

ATC code
  
none

ChemSpider
  
none

Pateclizumab is an immunomodulator. It binds to lymphotoxin alpha.

This drug was developed by Genentech/Roche.

References

Pateclizumab Wikipedia


Similar Topics